| Phase 3 |
| NCT06958328 |
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer |
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma |
Recruiting |
| NCT06998940 |
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or… |
Locally Advanced Pancreatic Adenocarcinoma |
Recruiting |
| NCT07409272 |
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either… |
Pancreatic Cancer |
Recruiting |
| NCT06625320 |
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic… |
Pancreatic Cancer |
Active, Not Recruiting |
| Phase 2 |
| NCT04150640 |
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in… |
Esophageal Adenocarcinoma |
Recruiting |
| NCT06821997 |
NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal… |
Borderline Resectable Pancreatic Ductal Adenocarcinoma |
Recruiting |
| NCT05854498 |
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal… |
Metastatic Colorectal Cancer |
Recruiting |
| NCT07076212 |
Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients… |
Metastatic Pancreatic Adenocarcinoma |
Recruiting |
| NCT03483038 |
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU… |
Pancreatic Adenocarcinoma |
Active, Not Recruiting |
| NCT03764553 |
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer |
Esophageal Cancer |
Active, Not Recruiting |
| NCT07521605 |
Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced… |
Rectal Cancer Patients |
Not Yet Recruiting |
| NCT04233866 |
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil… |
Metastatic Pancreatic Adenocarcinoma |
Active, Not Recruiting |
| NCT07570914 |
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as… |
Colorectal Cancer Liver Metastases (CRLM) |
Not Yet Recruiting |
| NCT07591831 |
Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer |
Platinum-resistant Recurrent Ovarian Cancer |
Not Yet Recruiting |
| Phase 1/2 |
| NCT07479732 |
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma |
Osteosarcoma |
Recruiting |
| Phase 1 |
| NCT05382559 |
A Study of ASP3082 in Adults With Advanced Solid Tumors |
Solid Tumor |
Recruiting |
| Not specified |
| NCT07474103 |
SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC |
Rectal Cancer, Adenocarcinoma |
Recruiting |